Skip to main content

Table 2 Clinical features of recurrent tumors

From: Is switching intravesical chemotherapeutic agents beneficial in short-term recurrent high-risk non-muscle-invasive bladder tumors? A 5-year retrospective study

 

Group A

Group B

p-value

T category (n%)

0.052

 Ta

36 (33.6)

46 (46.9)

 

 T1

71 (66.4)

52 (53.1)

 

Grade (n%) (WHO 2004)

0.258

 Low grade

44 (41.1)

48 (49.0)

 

 High grade

63 (58.9)

50 (51.0)

 

CIS (n%)

0.600

 No

105 (98.1)

94 (95.9)

 

 YES

2 (1.9)

4 (4.1)

 

Tumor size (n%)a

0.815

  < 3 cm

102 (95.3)

95 (96.9)

 

  ≥ 3 cm

5 (4.7)

3 (3.1)

 

Multifocal (n%)

0.072

 No

41 (38.3)

26 (26.5)

 

 YES

66 (61.7)

72 (73.5)

 
  1. aMaximum size of largest tumor resected